Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 18.10.2016 / 19:33 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- 1. Details of the person discharging managerial responsibilities / person closely associated a) Name Title: Mr First name: Alan Last name(s): Campbell 2. Reason for the notification a) Position / status Position: Member of the administrative or supervisory body b) Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Dialog Semiconductor Plc. b) LEI 529900QA2LORU6646N15 4. Details of the transaction(s) a) Description of the financial instrument, type of instrument, identification code Type: Share ISIN: GB0059822006 b) Nature of the transaction Receipt of shares - This transaction relates to the quarterly receipt by the non-executive director of shares in the Company as part of their annual remuneration in accordance with the policy approved by shareholders at the Company's 2016 Annual General Meeting. c) Price(s) and volume(s) Price(s) Volume(s) 33.9983 EUR 688 EUR d) Aggregated information Price Aggregated volume 33.9983 EUR 688.0000 EUR e) Date of the transaction 2016-09-28; UTC+2 f) Place of the transaction Name: XETRA MIC: XETR --------------------------------------------------------------------------- 18.10.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: Dialog Semiconductor Plc. Tower Bridge House, St. Katharine's Way E1W 1AA London United Kingdom Internet: www.dialog-semiconductor.com End of News DGAP News Service --------------------------------------------------------------------------- 30099 18.10.2016
DGAP-DD: Dialog Semiconductor Plc. english Notification and
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Omaha Productions Joins Forces with FanDuel for New Era
Strategic Partnership Between Omaha Productions and FanDuel Main Street Sports Group, known for its ownership of FanDuel Sports Network, has forged an exciting new partnership with Omaha Productions, led by Peyton Manning. This collaboration aims to innovate and co-produce premium sports content across various platforms, including linear, streaming, and digital. Enhanced...
Continue Reading
Brazil's Industrial Gears Market Set for Major Growth by 2033
Brazil's Industrial Gears Market Forecast: An Overview The Brazil industrial gears market has seen remarkable growth, currently valued at approximately US$ 448.83 million and projected to soar to US$ 677.42 million by 2033, reflecting a compound annual growth rate (CAGR) of 4.68% during the period from 2025 to 2033. Key Drivers Behind Market Expansion Currently, the...
Continue Reading
Explore Top Stocks by Warren Buffett for Long-Term Growth
Warren Buffett's investment playbook has shaped how investors think about stability and growth. When you look at the stocks he champions through Berkshire Hathaway, two giants leap out: Coca-Cola and Apple. These aren't just any stocks; they represent a strategy that thrives even when the markets are rocky. Coca-Cola: Resilience in a Shaky Market Coca-Cola (NYSE: KO) has...
Continue Reading
Affirm and Shopify Strengthen Partnership for Enhanced Services
Affirm's Landmark Partnership with Shopify Affirm Holdings Inc (NASDAQ: AFRM) has recently announced a major update about its collaboration with Shopify Inc (NYSE: SHOP), reinforcing their partnership to provide optimized payment solutions globally. This expanded agreement aims to enhance how consumers shop online while offering more flexibility in payment options. What...
Continue Reading
Trevi Therapeutics Achieves Breakthrough in Chronic Cough Treatment
Trevi Therapeutics Makes Strides with Haduvio for Chronic Cough Trevi Therapeutics, Inc. is making headlines as it has reported impressive topline results from its Phase 2a RIVER trial. This study evaluates Haduvio (oral nalbuphine ER), a potential breakthrough in the treatment for patients suffering from chronic cough, involving a diverse group of 66 individuals....
Continue Reading